Marcin Kolaczkowski

About Marcin Kolaczkowski

Marcin Kolaczkowski, With an exceptional h-index of 30 and a recent h-index of 22 (since 2020), a distinguished researcher at Uniwersytet Jagiellonski, specializes in the field of GPCRs, multimodal ligands, biased agonism, antipsychotics, antidepressants.

His recent articles reflect a diverse array of research interests and contributions to the field:

Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors

Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression

Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand

2-(4-fluorophenyl)-1-benzo[]imidazole as a promising template for the development of metabolically robust, 122GABA-A receptor-positive allosteric …

Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance

Application of automated machine learning in the identification of multi‐target‐directed ligands blocking PDE4B, PDE8A, and TRPA1 with potential use in the treatment of asthma …

Marcin Kolaczkowski Information

University

Position

Professor of the

Citations(all)

2351

Citations(since 2020)

1452

Cited By

1440

hIndex(all)

30

hIndex(since 2020)

22

i10Index(all)

69

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Marcin Kolaczkowski Skills & Research Interests

GPCRs

multimodal ligands

biased agonism

antipsychotics

antidepressants

Top articles of Marcin Kolaczkowski

Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors

Molecules

2024/1/24

Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression

European Journal of Medicinal Chemistry

2023/2/5

Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies

ACS omega

2023/10/5

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice

Pharmaceuticals

2023/1/24

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand

Frontiers in Neuroscience

2017/2/8

2-(4-fluorophenyl)-1-benzo[]imidazole as a promising template for the development of metabolically robust, 122GABA-A receptor-positive allosteric …

ACS Chemical Neuroscience

2023

Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance

Xenobiotica

2023/7/3

Application of automated machine learning in the identification of multi‐target‐directed ligands blocking PDE4B, PDE8A, and TRPA1 with potential use in the treatment of asthma …

Molecular Informatics

2023/7

In silico and in vitro assessment of carbonyl reductase 1 inhibition using ASP9521—A potent aldo-keto reductase 1C3 inhibitor with the potential to support anticancer therapy …

Molecules

2023/4/27

Dual Molecules Targeting 5-HT6 and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation

ACS Chemical Neuroscience

2023/4/4

Potential anti-amnesic activity of a novel multimodal derivative of salicylamide, JJGW08, in mice

Pharmaceuticals

2023/3/6

Ultrasound assisted one-pot synthesis and preliminary in vitro studies of salicylamide arylpiperazines as dual 5-HT1A/5-HT7 ligands

Journal of Molecular Structure

2023/3/5

2-(4-Fluorophenyl)-1H-benzo[d]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric …

ACS Chemical Neuroscience

2023/2/27

The 5-HT1A receptor biased agonist, NLX-204, shows rapid-acting antidepressant-like properties and neurochemical changes in two mouse models of depression

Behavioural Brain Research

2023/2/13

The use of machine learning-based sequential virtual screening in the search of new ligands of 5-HT6 receptor

Farmacja Polska

2022

Exploring the antiplatelet activity of serotonin 5-HT2A receptor antagonists bearing 6-fluorobenzo [d] isoxazol-3-yl) propyl) motif–as potential therapeutic agents in the …

Biomedicine & Pharmacotherapy

2022/1/1

Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders

2022/1/1

Novel Arylpiperazine Derivatives of Salicylamide with α1-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats

International Journal of Molecular Sciences

2022/12/24

Antipsychotic-and anxiolytic-like properties of a multimodal compound JJGW08 in rodents

International Journal of Molecular Sciences

2022/12/14

Spontaneous head twitches in aged rats: behavioral and molecular study

Psychopharmacology

2022/12

See List of Professors in Marcin Kolaczkowski University(Uniwersytet Jagiellonski)